Sildenafil Citrate Sublingual Tablets, 100 mg

Pharmacokinetic- pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Muirhead GJ, Rance DJ, Walker DK, Donald K, Wastall P.

Sildenafil Citrate Sublingual Tablets 100mg Technical Specification:

Findings from a recent phase 1 trial show that ASP-001, an investigational sildenafil oral spray for patients with erectile dysfunction, achieved therapeutic levels at a significantly faster rate compared with traditional sildenafil citrate tablets (Viagra), announced Aspargo Labs, the developer of the formulation, in a news release.1 “The rapid and enhanced absorption profile demonstrated by ASP-001 in this phase 1 study highlight its potential to address key unmet needs in the treatment of erectile dysfunction,” said Steven Kaplan, MD, Chief Medical Officer at Aspargo Labs, director of the Men’s Wellness Program at the Mount Sinai Health System, and a professor at the Icahn School of Medicine at Mount Sinai.1 “Many patients struggle with the inconvenience and lack of spontaneity associated with planning ahead to take a tablet and the requirement to fast or time their dosing. An oral spray formulation that achieves therapeutic levels quickly could represent a significant advancement in patient-centric therapy. If approved, ASP-001 would be a welcome addition to the treatment landscape, offering patients and their partners a novel and practical option to enhance their sexual health and overall quality of life.” Overall, data from the phase 1 study showed that ASP-001 achieved initial absorption within 5 minutes of administration. At this time point, the average amount of medication in the bloodstream was 0.615 ng/mL with ASP-001, vs 0 ng/mL with sildenafil tablets. The average level of medication in the bloodstream via mean plasma concentrations remained higher for those who received ASP-001 vs those who received sildenafil tablets for the first 30 minutes following administration.

What are the most common side effects of sildenafil?

In total, the open-label, single center, 2-way crossover study included 53 healthy, fasted male volunteers. Participants were randomly assigned to receive either 4 mL of ASP-001 or to 100 mg sildenafil tablets. All those included in the trial participated in at least a 10-hour fasting period and underwent a total of 24 plasma blood samples over 24 hours. In addition to the current phase 1 study, ASP-001 is also being assessed in a companion food-effect trial to compare the amount of active drug in participants’ plasma following an administration of the medication under both fed and fasted conditions.2 In total, the study plans to enroll 38 participants. Sildenafil oral spray is currently approved in Spain, Germany, the Netherlands, Ireland, Mexico and the United Kingdom. Comparative human pharmacokinetics and metabo- lism of single dose oral and intravenous sildenafil. Pharmacokinet- ics of sildenafil after single oral doses in healthy male subjects. Absolute bioavailability, food affects sildenafil citrate tablet and dose proportionality. Clinical safety of oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction. The study finds that 65% of patients using sublingual sildenafil achieved satisfactory erections, compared to 15% with placebo. This result indicates a statistically significant increase in treatment success rates (P = 0.005). The mean onset time for erection with sublingual sildenafil was 15.5 minutes, while placebo showed 30 minutes. This suggests a quicker effect onset, enhancing sexual responsiveness for patients. Reported side effects were mild, with headache in 10% of sublingual and 5% of placebo patients.

• This sublingual tablet is a fast-acting form of sildenafil.
• It is marketed for the treatment of erectile dysfunction.
• Always comply with prescribed dose and frequency.
• The medication may cause temporary visual or auditory side effects.
• Avoid grapefruit or herbal supplements unless approved by your doctor.
• Patients with vision or hearing problems should consult a doctor before use.
• The medication may cause a sudden drop in blood pressure in some individuals.
• Use with caution in patients with bleeding disorders.
• Discuss your complete medical history with your healthcare provider.
• Keep a record of doses taken and effects experienced.
• Seek emergency help if adverse reactions are severe.

Flushing and sweating were also noted but were well tolerated overall. The study indicates that 20 mg of sublingual sildenafil provides results comparable to 50 mg oral sildenafil in terms of efficacy. This demonstrates sildenafil 100mg hexal the potential for lower dosing with similar therapeutic outcomes.

The bioavailability of sublingual sildenafil may rival that of intravenous methods, bypassing first-pass metabolism. This indicates a higher efficiency and faster therapeutic onset compared to oral administration, which has a bioavailability around 41%. The Movement Disorders Prescriber's Guide to Parkinson's Disease , pp. 459 - 472Publisher: Cambridge University PressPrint publication year: 2025 Bernard, BA, Metman, LV, Levine, L, Ouyang, B, Leurgans, S, Goetz, CG. Sildenafil in the treatment of erectile dysfunction in Parkinson’s disease.

Mov Disord Clin Pract 2017; 4(3): 412–415.CrossRefGoogle ScholarPubMed Hussain, IF, Brady, CM, Swinn, MJ, Mathias, CJ, Fowler, CJ. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson’s disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry 2001; 71(3): 371–374.CrossRefGoogle ScholarPubMed Raffaele, R, Vecchio, I, Giammusso, B, Morgia, G, Brunetto, MB, Rampello, L.

Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson’s disease. Eur Urol 2002; 41(4): 382–386.CrossRefGoogle ScholarPubMed Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson’s disease.

• Sildenafil citrate sublingual tablets are available by prescription only.
• They are typically used when other erectile dysfunction medications are ineffective.
• The sublingual method provides quicker results than traditional pills.
• Patients should inform their doctor of all medications before use.
• Avoid using these tablets if allergic to sildenafil.
• The medication may cause dizziness or vision changes.
• Do not use these tablets with grapefruit or grapefruit juice.
• Overuse can lead to priapism, a prolonged erection requiring medical attention.
• The tablets are designed to degrade under the tongue, not for swallowing.
• Regular medical check-ups are recommended during treatment.
• Proper disposal of unused medication prevents misuse.

Mov Disord 2000; 15(2): 305–308.3.0.CO;2-W>CrossRefGoogle ScholarPubMed Bethesda: American Society of Health-System Pharmacists.

Traditional ED Medications

65% of patients on sublingual sildenafil achieved satisfactory erections compared to 15% in the placebo group. The average onset of action for sublingual sildenafil was 15.5 minutes, versus 30 minutes for placebo. Sublingual sildenafil administration offers advantages including faster onset and lower required dosage compared to oral forms. The study aims to evaluate the safety and efficacy of sublingual sildenafil versus placebo in erectile dysfunction. Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment J.

Usual Adult Dose for:

Urol. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Development and evaluation of an abridged, 5-item ver- sion of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Eardley I, Ellis P, Boolell M, Wulff M. Onset and dura- tion of action of sildenafil for the treatment of erectile dysfunction. Accessed on 31 December 2022 via Scholar Management of sexual dysfunction in Parkinson’s disease. Ther Adv Neurol Disord 2011; 4(6): 375–383.CrossRefGoogle ScholarPubMed Accessed on 31 December 2022 via Scholar Salonia, A, Rigatti, P, Montorsi, F. Sildenafil in erectile dysfunction: a critical review. Curr Med Res Opin 2003; 19(4): 241–262.CrossRefGoogle ScholarPubMed London: The Royal Pharmaceutical Society of Great Britain. Accessed on 31 December 2022 via Scholar Truven Health Analytics, Greenwood Village, Colorado, USA.

Is Sildenafil Citrate 100mg Sublingual suitable for regular use?When used responsibly and as directed, Sildenafil Citrate 100mg Sublingual can be suitable for regular use. Many men choose it for its predictable performance, ease of use, and consistent results that support confidence without disrupting daily routines.

Aspargo now plans to file a new drug application with the FDA to support regulatory approval of ASP-001 in the United States. Aspargo is also working on regulatory submissions to support approval of ASP-001 in Japan as well as several countries in the Middle East and South America. “Our innovative oral spray technology has been carefully developed to provide a novel approach for administering medication, simplifying the process of drug consumption,” said Michael Demurjian, CEO of Aspargo Labs, in the news release.1 “The study data provides evidence for the safety and pharmacokinetic profile of our oral spray technology. Our research has demonstrated that ASP-001 exhibits rapid absorption, surpassing the absorption rate of Viagra tablets in the initial minutes after administration. We look forward to collaborating with the FDA to file an NDA for ASP-001 for the treatment of ED under the 505(b)2 regulatory pathway and are enthusiastic about the opportunity to make this drug available to patients in the US.” Aspargo Labs announces data on first oral spray for erectile dysfunction, ASP-001, showing two times faster absorption compared to Viagra tablets.

Pulmonary hypertension

Aspargo announces completion of dosing of all subjects in sildenafil oral suspension bioavailability study and initiation of dosing in companion food-effect study. Background : The aim of the present study was to show the efficacy and safety of sublingual sildenafil and to determine whether lower doses cause the same effect with a faster onset of action in this mode of application. Methods : Fourty consecutive patients with erectile dysfunction for more than three months were included in the study. The mean age was 55 years (range, 25-65). Serum glucose and testosterone levels, lipid profile and erectile function scores were obtained in all patients. Accessed on 31 December 2022 via Scholar Copyright © 2022, Treasure Island (FL): StatPearls Publishing LLC.Google Scholar Summary of product characteristics – Viagra 25 mg film-coated tablets. Electronic Medicines Compendium: Viagra 25 mg film-coated tablets – summary of product characteristics (SmPC) – (emc). Accessed on 31 December 2022 via Scholar Accessibility compliance for the HTML of this chapter is currently unknown and may be updated in the future.

Top 20 FAQs

Twenty patients received placebos and the other 20 patients received 20 mg sublingual sildenafil in a double blind randomized design. Results : The effect of sildenafil on erection was significantly higher than that of placebo. Sixty-five percent of patients (13/20) who received sublingual sildenafil achieved satisfying erections and coitus, whereas the rate was 15% in the placebo group (3/20). The mean onset sildenafil 100 mg tab of action with sublingual sildenafil was 15.5 min and lasted for an average of 40 min. Minimal headaches, sweating and flushing were noted as the side-effects.

DIRECTION OF USE:

Conclusions : 20 mg sublingual sildenafil is safe and effective in the treatment of erectile dysfunction. Sublingual administration has some advantages as it is not effected by food ingestion and quickly appears in the circulation. These advantages provide a faster onset of action with a lower dose when compared to oral sildenafil. Sublingual use of sildenafil may be more cost-effective and possibly provides a more predictable onset of action. Twenty mg of sublingual sildenafil shows a significantly higher efficacy than placebo in erectile dysfunction treatment.